APUS — Apimeds Pharmaceuticals US Share News
0.000.00%
Last trade - 00:00Brief: Apimeds Pharmaceuticals US Enters Assignment And Transfer Agreement With Freet On August 19
Brief: Apimeds Pharmaceuticals Us Inc Vin Menon Continues To Serve As The Company’S Chief Executive Officer
Brief: Apimeds Pharmaceuticals Appoints Youngjik Cho As Chairman Of Board
Brief: Apimeds Pharmaceuticals Us Inc. Announces Material Breach Of Merger Agreement By Inscobee Inc And Apimeds Inc
Brief: E.F. Hutton Advises On Strategic Merger Between Apimeds And Mindwave
Brief: Apimeds And Mindwave Announce Merger, Integrating Biotech Growth With AI
U.S. STOCKS ON THE MOVE-Vaccine makers, NextDecade, Alaska Air Group
U.S. STOCKS ON THE MOVE-Warner Bros Discovery, Cocrystal Pharma, Prenetics Global
Apimeds Pharma jumps as FDA backs faster approval path for non-opioid pain drugs
U.S. STOCKS ON THE MOVE-Lennox, Camtek, J.M. Smucker
U.S. STOCKS ON THE MOVE-Adobe , GE Vernova, CleanCore
Apimeds Pharma jumps as FDA backs faster approval path for non-opioid pain drugs
Brief: Apimeds Welcomes FDA Draft Guidance As Catalyst For Advancing Apitox Non-Opioid Pain Program
Brief: Apimeds Pharmaceuticals Us Inc - On May 30, Appoints Erick J. Frim As CFO Replacing Mark Corrao